This enhanced blood supply delivers oxygen, nutrients, and repair cells to damaged tissues, accelerating healing across diverse tissue types including muscle, tendon, bone, and gastrointestinal mucosa
What is the theoretical rationale people give for this stack
In pre-clinical models, BPC 157 has been observed to: Upregulate vascular endothelial growth factor (VEGF) , promoting new blood vessel formation in damaged tissue Modulate nitric oxide (NO) synthesis pathways, influencing vascular tone and healing cascades Interact with the growth hormone receptor system , potentially amplifying downstream tissue repair signaling Demonstrate cytoprotective effects along the gastrointestinal tract its native home territory as a gastric peptide Exhibit apparent neuroprotective properties in rodent models of CNS injury BPC 157 stability in gastric acid unusual for peptides has made it a focus of GI mucosal repair research
That is one reason longer phase 3 trials drew so much interest, since the ceiling had not announced itself yet
J.BarclayE.JaegerE
Glioma, melatonin, and radiotherapy [PMID: 16778225] Laboratory literature summary: Glioma, melatonin, and radiotherapy